R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial

PURPOSE: Chemotherapy with or without radiotherapy is the standard in patients with initially nonmetastatic unresectable pancreatic cancer. Additional surgery is in discussion. The CONKO-007 multicenter randomized trial examines the value of radiotherapy. Our interim analysis showed a significant ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Fietkau, R., Grützmann, R., Wittel, U. A., Croner, R. S., Jacobasch, L., Neumann, U. P., Reinacher-Schick, A., Imhoff, D., Boeck, S., Keilholz, L., Oettle, H., Hohenberger, W. M., Golcher, H., Bechstein, W. O., Uhl, W., Pirkl, A., Adler, W., Semrau, S., Rutzner, S., Ghadimi, M., Lubgan, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801312/
https://www.ncbi.nlm.nih.gov/pubmed/32914237
http://dx.doi.org/10.1007/s00066-020-01680-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801312/
https://www.ncbi.nlm.nih.gov/pubmed/32914237
http://dx.doi.org/10.1007/s00066-020-01680-2

Ejemplares similares